Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis.

Malagón T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J, Brisson M.

Lancet Infect Dis. 2012 Oct;12(10):781-9. doi: 10.1016/S1473-3099(12)70187-1. Epub 2012 Aug 22. Review.

PMID:
22920953
[PubMed - indexed for MEDLINE]
2.

Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models.

Bogaards JA, Kretzschmar M, Xiridou M, Meijer CJ, Berkhof J, Wallinga J.

PLoS Med. 2011 Dec;8(12):e1001147. doi: 10.1371/journal.pmed.1001147. Epub 2011 Dec 20.

PMID:
22205887
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model.

Jit M, Chapman R, Hughes O, Choi YH.

BMJ. 2011 Sep 27;343:d5775. doi: 10.1136/bmj.d5775.

PMID:
21951758
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.

Praditsitthikorn N, Teerawattananon Y, Tantivess S, Limwattananon S, Riewpaiboon A, Chichareon S, Ieumwananonthachai N, Tangcharoensathien V.

Pharmacoeconomics. 2011 Sep;29(9):781-806. doi: 10.2165/11586560-000000000-00000.

PMID:
21838332
[PubMed - indexed for MEDLINE]
5.

Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide.

Bilcke J, Beutels P, Brisson M, Jit M.

Med Decis Making. 2011 Jul-Aug;31(4):675-92. doi: 10.1177/0272989X11409240. Epub 2011 Jun 8.

PMID:
21653805
[PubMed - indexed for MEDLINE]
6.

Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal.

Hutubessy R, Henao AM, Namgyal P, Moorthy V, Hombach J.

BMC Med. 2011 May 12;9:55. doi: 10.1186/1741-7015-9-55.

PMID:
21569407
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.

Jit M, Demarteau N, Elbasha E, Ginsberg G, Kim J, Praditsitthikorn N, Sinanovic E, Hutubessy R.

BMC Med. 2011 May 12;9:54. doi: 10.1186/1741-7015-9-54.

PMID:
21569406
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence.

Bogaards JA, Coupé VM, Xiridou M, Meijer CJ, Wallinga J, Berkhof J.

Epidemiology. 2011 Jul;22(4):505-15. doi: 10.1097/EDE.0b013e31821d107b. Erratum in: Epidemiology. 2011 Nov;22(6):881.

PMID:
21540743
[PubMed - indexed for MEDLINE]
9.

Estimating the impact of human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali.

Tracy L, Gaff HD, Burgess C, Sow S, Gravitt PE, Tracy JK.

Clin Infect Dis. 2011 Mar 1;52(5):641-5. doi: 10.1093/cid/ciq190. Epub 2011 Jan 20.

PMID:
21252142
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Proceedings of the Modeling Evidence in HPV Pre-Conference Workshop in Malmö, Sweden, May 9-10, 2009.

Craig BM, Brisson M, Chesson H, Giuliano AR, Jit M.

Clin Ther. 2010 Aug;32(8):1546-64. doi: 10.1016/j.clinthera.2010.06.017.

PMID:
20728767
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Using economic evaluation in policy decision-making in Asian countries: mission impossible or mission probable?

Yothasamut J, Tantivess S, Teerawattananon Y.

Value Health. 2009 Nov-Dec;12 Suppl 3:S26-30. doi: 10.1111/j.1524-4733.2009.00623.x. Review.

PMID:
20586976
[PubMed - indexed for MEDLINE]
12.

Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis.

Van de Velde N, Brisson M, Boily MC.

Vaccine. 2010 Jul 26;28(33):5473-84. doi: 10.1016/j.vaccine.2010.05.056. Epub 2010 Jun 2.

PMID:
20573580
[PubMed - indexed for MEDLINE]
13.

The Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) initiative: a country-driven, multi-partner program to support evidence-based decision making.

Senouci K, Blau J, Nyambat B, Coumba Faye P, Gautier L, Da Silva A, Favorov MO, Clemens JD, Stoeckel P, Gessner BD.

Vaccine. 2010 Apr 19;28 Suppl 1:A26-30. doi: 10.1016/j.vaccine.2010.02.028.

PMID:
20412992
[PubMed - indexed for MEDLINE]
14.

Recommendations for increasing the use of HIV/AIDS resource allocation models.

Lasry A, Richter A, Lutscher F.

BMC Public Health. 2009 Nov 18;9 Suppl 1:S8. doi: 10.1186/1471-2458-9-S1-S8.

PMID:
19922692
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A cost-utility analysis of adding a bivalent or quadrivalent HPV vaccine to the Irish cervical screening programme.

Dee A, Howell F.

Eur J Public Health. 2010 Apr;20(2):213-9. doi: 10.1093/eurpub/ckp141. Epub 2009 Oct 28.

PMID:
19864366
[PubMed - indexed for MEDLINE]
Free Article
16.

The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa.

Sinanovic E, Moodley J, Barone MA, Mall S, Cleary S, Harries J.

Vaccine. 2009 Oct 19;27(44):6196-202. doi: 10.1016/j.vaccine.2009.08.004. Epub 2009 Aug 19. Erratum in: Vaccine. 2010 Aug 9;28(35):5755.

PMID:
19698807
[PubMed - indexed for MEDLINE]
17.

Economic evaluation of human papillomavirus vaccination in developed countries.

Brisson M, Van de Velde N, Boily MC.

Public Health Genomics. 2009;12(5-6):343-51. doi: 10.1159/000214924. Epub 2009 Aug 11. Review.

PMID:
19684446
[PubMed - indexed for MEDLINE]
18.

Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.

Ginsberg GM, Edejer TT, Lauer JA, Sepulveda C.

Vaccine. 2009 Oct 9;27(43):6060-79. doi: 10.1016/j.vaccine.2009.07.026. Epub 2009 Jul 31.

PMID:
19647813
[PubMed - indexed for MEDLINE]
19.

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group.

PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097. Epub 2009 Jul 21. No abstract available.

PMID:
19621072
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

WHO Guide for standardisation of economic evaluations of immunization programmes.

Walker DG, Hutubessy R, Beutels P.

Vaccine. 2010 Mar 8;28(11):2356-9. doi: 10.1016/j.vaccine.2009.06.035. Epub 2009 Jun 28. Review.

PMID:
19567247
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk